Home
Scientific News
Structural Heart Disease
Coronary Disease
Peripheral Vascular Disease
Pharmacology
Educational Newsletters for Fellows
Educational Webinars
Other Content
Congresses
SOLACI-SOCIME 2025 Congress
International Congresses
SOLACI Congresses
Upcoming Events
SOLACI Areas
Sessions
Venezuela Sessions 2025
Costa Rica Sessions 2025
Previous Sessions
About SOLACI Sessions
Authorities
SOLACI Sessions News
ProEducar
Educational Newsletters
Courses for Fellows
The Fellow’s Corner
ProEducar Videos and Webinars
ProEducar News
SOLACI Research
2025 SOLACI Research Grant
LATAM-SOLACI Peripheral Registry
LATAM-BIF SOLACI Registry
Participate in our LATAM-SOLACI Peripheral Registries
SOLACI/SIAC Clinical Guidelines TAVR vs SAVR
SOLACI-SIAC LM Revascularization Guidelines
Authorities
Videos and Webinars
Research News
SOLACI Peripheral
LATAM-SOLACI Peripheral Registry
Videos and Webinars
Authorities
SOLACI Peripheral News
MIL Group
Activities and Initiatives
Videos and Webinars
History, Mission, and Vision
Authorities
Mil Group News
CHIP LATAM SOLACI
Authorities
CHIP LATAM SOLACI News
SOL SOLACI
Authorities
SOL SOLACI News
Congenital Heart Disease
Authorities
Congenital Heart Disease News
SOLACI Technologists and Nurses
Board of Directors
Videos and Webinars
SOLACI Technologists and Nurses News
About SOLACI
About us
Board of Directors
List of members
Become A SOLACI Member
Update your Info (members)
Related Organizations
Institutional News
Contact
Search
Buscar
Buscar
Congreso SOLACI
SOLACI & SBHCI 2026
Bienvenidos al SOLACI & SBHCI 2026
Highlights
Información General
Autoridades
Certificados SOLACI-SOCIME 2025
Facebook
Instagram
Linkedin
Twitter
Youtube
Home
Scientific News
Structural Heart Disease
Coronary Disease
Peripheral Vascular Disease
Pharmacology
Educational Newsletters for Fellows
Educational Webinars
Other Content
Congresses
SOLACI-SOCIME 2025 Congress
International Congresses
SOLACI Congresses
Upcoming Events
SOLACI Areas
Sessions
Venezuela Sessions 2025
Costa Rica Sessions 2025
Previous Sessions
About SOLACI Sessions
Authorities
SOLACI Sessions News
ProEducar
Educational Newsletters
Courses for Fellows
The Fellow’s Corner
ProEducar Videos and Webinars
ProEducar News
SOLACI Research
2025 SOLACI Research Grant
LATAM-SOLACI Peripheral Registry
LATAM-BIF SOLACI Registry
Participate in our LATAM-SOLACI Peripheral Registries
SOLACI/SIAC Clinical Guidelines TAVR vs SAVR
SOLACI-SIAC LM Revascularization Guidelines
Authorities
Videos and Webinars
Research News
SOLACI Peripheral
LATAM-SOLACI Peripheral Registry
Videos and Webinars
Authorities
SOLACI Peripheral News
MIL Group
Activities and Initiatives
Videos and Webinars
History, Mission, and Vision
Authorities
Mil Group News
CHIP LATAM SOLACI
Authorities
CHIP LATAM SOLACI News
SOL SOLACI
Authorities
SOL SOLACI News
Congenital Heart Disease
Authorities
Congenital Heart Disease News
SOLACI Technologists and Nurses
Board of Directors
Videos and Webinars
SOLACI Technologists and Nurses News
About SOLACI
About us
Board of Directors
List of members
Become A SOLACI Member
Update your Info (members)
Related Organizations
Institutional News
Contact
Home
Scientific News
Structural Heart Disease
Coronary Disease
Peripheral Vascular Disease
Pharmacology
Educational Newsletters for Fellows
Educational Webinars
Other Content
Congresses
SOLACI-SOCIME 2025 Congress
International Congresses
SOLACI Congresses
Upcoming Events
SOLACI Areas
Sessions
Venezuela Sessions 2025
Costa Rica Sessions 2025
Previous Sessions
About SOLACI Sessions
Authorities
SOLACI Sessions News
ProEducar
Educational Newsletters
Courses for Fellows
The Fellow’s Corner
ProEducar Videos and Webinars
ProEducar News
SOLACI Research
2025 SOLACI Research Grant
LATAM-SOLACI Peripheral Registry
LATAM-BIF SOLACI Registry
Participate in our LATAM-SOLACI Peripheral Registries
SOLACI/SIAC Clinical Guidelines TAVR vs SAVR
SOLACI-SIAC LM Revascularization Guidelines
Authorities
Videos and Webinars
Research News
SOLACI Peripheral
LATAM-SOLACI Peripheral Registry
Videos and Webinars
Authorities
SOLACI Peripheral News
MIL Group
Activities and Initiatives
Videos and Webinars
History, Mission, and Vision
Authorities
Mil Group News
CHIP LATAM SOLACI
Authorities
CHIP LATAM SOLACI News
SOL SOLACI
Authorities
SOL SOLACI News
Congenital Heart Disease
Authorities
Congenital Heart Disease News
SOLACI Technologists and Nurses
Board of Directors
Videos and Webinars
SOLACI Technologists and Nurses News
About SOLACI
About us
Board of Directors
List of members
Become A SOLACI Member
Update your Info (members)
Related Organizations
Institutional News
Contact
Artículos del autor
solaci
Coronary disease
PCI on Native Arteries or Saphenous Vein Grafts: Which Has Better Prognosis?
New revascularization after coronary artery bypass graft (CABG) is often needed, be it because of severe bridge...
solaci
-
21 June, 2022
Institutional News
SOLACI-Medtronic Webinar | TAVR: What is the appropriate strategy in hostile scenarios?
solaci
-
16 June, 2022
Chronic Ischemic cardiopathy
Hand Function after Distal Radial Access: Is it Safe?
The benefit of the transradial approach in percutaneous interventions is well known. Its main limitation is radial...
solaci
-
16 June, 2022
Acute coronary syndromes
The Current Role of Thrombus Aspiration in Primary PCI
In general, thrombus aspiration in acute myocardial infarction (AMI) has not been shown beneficial by large studies....
solaci
-
15 June, 2022
Chronic Ischemic cardiopathy
FFR and IFR: Are We Talking About the Same Thing?
To evaluate borderline coronary lesions (a 40% to 70% obstruction), determining associated ischemia is paramount. For this...
solaci
-
14 June, 2022
Institutional News
Sign Up for SOLACI-SOCIME 2022 with 25% OFF
You can now take part in one of the most relevant events of the year in interventional...
solaci
-
13 June, 2022
Coronary disease
Using Biolimus-Coated Balloons for Treating Small-Vessel Disease Yields Promising Results
Drug-eluting balloons have demonstrated safety and effectiveness in the treatment of small-vessel coronary artery disease and in-stent...
solaci
-
13 June, 2022
Structural heart disease
TAVR, More Information Supports Its Use
TAVR has been reported beneficial in the treatment of high and intermediate risk patients but, initially, randomized...
solaci
-
10 June, 2022